GRANT SEAN (Chief Financial Officer) sold 4.2% of their position (4.95K shares) of VERA THERAPEUTICS, INC. on the open market
Open‑market sale worth $207.8K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 2/25/2026ACC: 0001872792-26-000004
Officer· Chief Financial Officer
Since Jul 2021
-4.95K
Net shares
Net seller
$207.8K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
4.95K disposed
Non-Derivative Transactions1
Class A Common Stock
Direct
Shares
−4.95K
Price / share
$41.98
Trade value
$207.78K
% of position
4.2%
2/23/2026
119.13K→114.18K
Total
Net shares
−4.95K
Net value
-$207.78K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Class A Common Stock Direct | 2/23/2026 | S · Sale | −4.95K | $41.98 | $207.78K | 4.2% | 119.13K | 114.18K |
| Total | −4.95K | -$207.78K | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)1
Class A Common Stock
IndirectShares owned5K
Total
5K indirect5K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Class A Common Stock | 5K | Indirect |
| Total | 5K | 5K indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported